{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:49Z","timestamp":1787021989838,"version":"build-2736575974"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["457575"],"award-info":[{"award-number":["457575"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council (AU)","award":["632647"],"award-info":[{"award-number":["632647"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164193","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T13:38:40Z","timestamp":1476106720000},"page":"e0164193","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Michelle H. T.","family":"Ta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina G.","family":"Schwensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuresh","family":"Korgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna E.","family":"Ozimek-Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline K.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Peduto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopala K.","family":"Rangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2010.457","article-title":"mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression","volume":"79","author":"TB Huber","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ackd.2010.01.006","article-title":"Treatment Strategies and Clinical Trial Design in ADPKD","volume":"17","author":"VE Torres","year":"2010","journal-title":"Adv Chronic Kid Dis"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","article-title":"mTOR signaling in polycystic kidney disease","volume":"17","author":"O Ibraghimov-Beskrovnaya","year":"2011","journal-title":"Trends Mol Med"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"N Hay","year":"2004","journal-title":"Genes Dev"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease","volume":"16","author":"Y Tao","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease","volume":"30","author":"M Wu","year":"2007","journal-title":"Kidney & blood pressure research"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"JM Shillingford","year":"2010","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ki.2009.147","article-title":"Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis","volume":"76","author":"VH Gattone II","year":"2009","journal-title":"Kidney Int"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease","volume":"363","author":"AL Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease","volume":"363","author":"G Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1600-6143.2010.03152.x","article-title":"Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?","volume":"10","author":"G Canaud","year":"2010","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"14","key":"ref12","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"JM Shillingford","year":"2006","journal-title":"Proc Nat Acad Sci USA"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1159\/000320149","article-title":"Early cyst growth is associated with the increased nuclear expression of cyclin D1\/Rb protein in an autosomal-recessive polycystic kidney disease rat model","volume":"117","author":"K Schwensen","year":"2011","journal-title":"Nephron (Exp Nephrol)"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"VH Gattone 2nd","year":"2003","journal-title":"Nature medicine"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1681\/ASN.2004030180","article-title":"Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy","volume":"16","author":"RGB Bonegio","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.ki.5000161","article-title":"Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis","volume":"69","author":"MJ Wu","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/nep.12045","article-title":"Role of interstitial inflammation in the pathogenesis of polycystic kidney disease","volume":"18","author":"MH Ta","year":"2013","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease","volume":"23","author":"Z Novalic","year":"2012","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000101828","article-title":"Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease","volume":"30","author":"JK Phillips","year":"2007","journal-title":"Kidney & blood pressure research"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"F574","DOI":"10.1152\/ajprenal.00411.2012","article-title":"Chronic effects of dietary vitamin D deficiency without increased calcium supplementation on the progression of experimental polycystic kidney disease","volume":"305","author":"GK Rangan","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref21","unstructured":"Council NHaMR. Australian code for the care and use of aniamls for scientific purposes. 8th Edition ed: National Health and Medical Research Council; 2013."},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5527\/wjn.v5.i4.339","article-title":"Constitutive renal Rel\/nuclear factor-kappaB expression in Lewis polycystic kidney disease rats","volume":"5","author":"MH Ta","year":"2016","journal-title":"World J Nephrol"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/ndt\/gfm191","article-title":"Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis","volume":"22","author":"GK Rangan","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"e12196","DOI":"10.14814\/phy2.12196","article-title":"Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease","volume":"2","author":"MH Ta","year":"2014","journal-title":"Physiological reports"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"F313","DOI":"10.1152\/ajprenal.00180.2006","article-title":"Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase","volume":"292","author":"MH de Borst","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"F298","DOI":"10.1152\/ajprenal.90628.2008","article-title":"Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR","volume":"296","author":"CM Elks","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1681\/ASN.2005030297","article-title":"IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease","volume":"16","author":"W Mu","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"I Zafar","year":"2010","journal-title":"Kidney Int"},{"issue":"110","key":"ref29","first-page":"9","article-title":"Renal protection: progression, regression, remission from nephropathy beyond blood pressure control","author":"G Remuzzi","year":"2000","journal-title":"Int J Clin Pract Suppl"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.ju.0000100700.13657.36","article-title":"Spontaneous neonatal regression of prenatally detected renal cysts in autosomal dominant polycystic kidney disease","volume":"171","author":"L Hammond","year":"2004","journal-title":"J Urol"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"JJ Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMe1006925","article-title":"mTOR Inhibitors in Polycystic Kidney Disease","volume":"363","author":"T Watnick","year":"2010","journal-title":"N Engl J Med"},{"key":"ref33","article-title":"Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment","volume":"3","author":"C Halvorson","year":"2010","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"13","key":"ref34","first-page":"1259","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease","volume":"368","author":"VE Torres","year":"2013","journal-title":"N Engl J Med"},{"issue":"Pt 1","key":"ref35","first-page":"714","article-title":"Influence of rat strain on rapamycin's kidney effects","volume":"25","author":"JF DiJoseph","year":"1993","journal-title":"Transplantation proceedings"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/TP.0b013e3181b24463","article-title":"Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction","volume":"88","author":"J Rovira","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.ajkd.2009.12.003","article-title":"Why Do Patients Develop Proteinuria With Sirolimus? Do We Have the Answer?","volume":"55","author":"JR Chapman","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00002018-200528020-00006","article-title":"Benefit-risk assessment of sirolimus in renal transplantation","volume":"28","author":"DR Kuypers","year":"2005","journal-title":"Drug safety"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus","volume":"20","author":"V Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"N Perico","year":"2010","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref41","article-title":"Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease","author":"AL Serra","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"F1597","DOI":"10.1152\/ajprenal.00430.2009","article-title":"Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease","volume":"297","author":"M Wu","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats","volume":"26","author":"C Renken","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","article-title":"Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD)","volume":"1812","author":"J Norman","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"SN Sehgal","year":"2003","journal-title":"Transplantation proceedings"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/cbt.2.3.360","article-title":"Rapamycins: mechanism of action and cellular resistance","volume":"2","author":"S Huang","year":"2003","journal-title":"Cancer biology & therapy"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/j.1460-2075.1996.tb00398.x","article-title":"Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation","volume":"15","author":"L Beretta","year":"1996","journal-title":"EMBO"},{"issue":"14","key":"ref48","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1074\/jbc.M007758200","article-title":"Rapamycin-insensitive Regulation of 4E-BP1 in Regenerating Rat Liver","volume":"276","author":"P Jiang Y-","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease","volume":"3","author":"CL Edelstein","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref50","article-title":"Concomitant use of rapamycin and rosiglitazone delays the progression of polycystic kidney disease in Han:SPRD rats: A study of the mechanism of action","author":"C Liu","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref51","article-title":"Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells","author":"L de Stephanis","year":"2016","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1172\/JCI118690","article-title":"Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy","volume":"97","author":"K Muraoka","year":"1996","journal-title":"The Journal of clinical investigation"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3109\/00207454.2012.721827","article-title":"Rapamycin preconditioning attenuates transient focal cerebral ischemia\/reperfusion injury in mice","volume":"122","author":"L Yin","year":"2012","journal-title":"The International journal of neuroscience"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.transproceed.2010.04.013","article-title":"Rapamycin inhibits activator protein-1 but not nuclear factor-kappaB activity of mature bone marrow-derived dendritic cells","volume":"42","author":"GY Wang","year":"2010","journal-title":"Transplantation proceedings"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"A Oeckinghaus","year":"2011","journal-title":"Nature immunology"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","article-title":"Akt-dependent regulation of NF-\u03baB is controlled by mTOR and Raptor in association with IKK","volume":"22","author":"HC Dan","year":"2008","journal-title":"Genes Dev"},{"issue":"6748","key":"ref57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/43466","article-title":"NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase","volume":"401","author":"ON Ozes","year":"1999","journal-title":"Nature"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1158\/0008-5472.CAN-09-0474","article-title":"RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and downregulation of PTEN","volume":"69","author":"S Park","year":"2009","journal-title":"Cancer research"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3181\/0807-RM-215","article-title":"Structural and functional analyses of liver cysts from the BALB\/c-cpk mouse model of polycystic kidney disease","volume":"234","author":"MN Muchatuta","year":"2009","journal-title":"Exp Biol Med"},{"issue":"17","key":"ref60","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1093\/hmg\/ddp272","article-title":"Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3","volume":"18","author":"R Tammachote","year":"2009","journal-title":"Hum Mol Gen"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00467-007-0692-y","article-title":"Defects in ciliary localization of Nek8 is associated with cystogenesis","volume":"23","author":"ML Trapp","year":"2008","journal-title":"Ped Nephrol"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ajhg.2008.02.017","article-title":"Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia","volume":"82","author":"C Bergmann","year":"2008","journal-title":"Am J Hum Gen"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1469-7580.2008.00918.x","article-title":"Alterations in renal cilium length during transient complete ureteral obstruction in the mouse","volume":"213","author":"L Wang","year":"2008","journal-title":"J Anat"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ndt\/gfm743","article-title":"Renal cilia display length alterations following tubular injury and are present early in epithelial repair","volume":"23","author":"E Verghese","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1681\/ASN.2008101105","article-title":"Renal primary cilia lengthen after acute tubular necrosis","volume":"20","author":"E Verghese","year":"2009","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"4","key":"ref66","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1523-1755.2003.00863.x","article-title":"Delayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant mice","volume":"63","author":"NE Brown","year":"2003","journal-title":"Kidney Int"},{"issue":"9359","key":"ref67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(03)12662-1","article-title":"Polycystic kidney disease\u2014the ciliary connection","volume":"361","author":"AC Ong","year":"2003","journal-title":"Lancet (London, England)"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.0400073101","article-title":"PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells","volume":"101","author":"M-Z Zhang","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"issue":"10","key":"ref69","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease","volume":"15","author":"GJ Pazour","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"4","key":"ref70","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/labinvest.3700253","article-title":"Cilium-generated signaling and cilia-related disorders","volume":"85","author":"J Pan","year":"2005","journal-title":"Lab Invest"},{"issue":"suppl 1","key":"ref71","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.ASN.0000067652.51441.21","article-title":"Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure","volume":"14","author":"JV Bonventre","year":"2003","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"GM Fick","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.transproceed.2009.02.005","article-title":"Hypertension Induced by Immunosuppressive Drugs: A Comparative Analysis Between Sirolimus and Cyclosporine","volume":"41","author":"F Reis","year":"2009","journal-title":"Transplantation proceedings"},{"issue":"8","key":"ref74","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","author":"I Zafar","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"ref75","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/01.hjh.0000239304.01496.83","article-title":"Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis","volume":"24","author":"X-M Gao","year":"2006","journal-title":"J Hypertens"},{"issue":"3","key":"ref76","first-page":"223","article-title":"Rapamycin inhibits the mTOR\/p70S6K pathway and attenuates cardiac fibrosis in adriamycin-induced dilated cardiomyopathy","volume":"61","author":"S-Y Yu","year":"2013","journal-title":"Thoracic Cardiovasc Surg"},{"issue":"10","key":"ref77","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","author":"JM Shillingford","year":"2012","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref78","article-title":"An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease","author":"K Ravichandran","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"ref79","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","article-title":"An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"23","author":"K Ravichandran","year":"2014","journal-title":"Hum Mol Gen"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","article-title":"Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor","volume":"16","author":"MR Janes","year":"2010","journal-title":"Nature medicine"},{"issue":"1","key":"ref81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","article-title":"The HALT polycystic kidney disease trials: design and implementation","volume":"5","author":"AB Chapman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"ref82","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"WN Leonhard","year":"2011","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T22:22:30Z","timestamp":1657405350000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164193"}},"subtitle":[],"editor":[{"given":"David","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":82,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164193","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]}}}